# Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression

> **NCT07247006** · PHASE2 · NOT_YET_RECRUITING · sponsor: **University of Rochester** · enrollment: 25 (estimated)

## Conditions studied

- Treatment Resistant Depression (TRD)
- Chronic Pain

## Interventions

- **DRUG:** Ketamine hydrochloride injection

## Key facts

- **NCT ID:** NCT07247006
- **Lead sponsor:** University of Rochester
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-06
- **Primary completion:** 2028-01
- **Final completion:** 2028-03
- **Target enrollment:** 25 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07247006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07247006, "Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07247006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*